Clearline Capital LP Avita Medical, Inc. Transaction History

Clearline Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$13.84 - $20.79 $410,785 - $617,067	-29,681 Reduced 58.96%	20,662 $301,000
Q2 2021 Aug 16, 2021	BUY	$17.23 - $22.02 $188,444 - $240,832	10,937 Added 27.75%	50,343 $1.03 Million
Q1 2021 May 17, 2021	SELL	$18.38 - $28.41 $942,894 - $1.46 Million	-51,300 Reduced 56.56%	39,406 $781,000
Q4 2020 Feb 16, 2021	BUY	$17.55 - $27.2 $1.59 Million - $2.47 Million	90,706 New	90,706 $1.69 Million

5.96M

35.5K

38K

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $299M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.